Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublication notes were updated to indicate that PubMed publications are automatically filled and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.4%

- Check20 days agoChange DetectedThe government funding/operational status notice banner was removed from the page; trial details and location information remained unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedThe updates appear to be minor formatting and text adjustments on the Study Details page, with no changes to the study design, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page version has been updated to v3.0.2, replacing v3.0.1. The 'Back to Top' navigation element has been removed.SummaryDifference0.1%

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.